Established in 2016 and based in India, Genes2Me is a pioneer manufacturer of the most promising and unfaltering in vitro diagnostic solutions. We are recognized for providing the most robust and cost-effective solutions across the globe bringing impactful changes in the diagnostic and patient care industry.

Our product portfolio includes molecular Next Generation Sequencing (NGS) clinical panels, point-of-care (POC) testing solutions, RT-PCR and instruments, rapid antigen/antibody testing kits, and molecular biology reagents. All our solutions are CE-IVD marked assuring our clients of unparalleled quality and compliance with international standards.